Provided by Tiger Trade Technology Pte. Ltd.

Quest Diagnostics

227.06
-1.3300-0.58%
Post-market: 227.060.00000.00%17:40 EDT
Volume:927.42K
Turnover:211.11M
Market Cap:25.06B
PE:24.11
High:229.80
Open:228.51
Low:226.81
Close:228.39
52wk High:248.84
52wk Low:171.18
Shares:110.37M
Float Shares:110.00M
Volume Ratio:0.77
T/O Rate:0.84%
Dividend:3.32
Dividend Rate:1.46%
EPS(TTM):9.42
EPS(LYR):8.75
ROE:14.60%
ROA:6.40%
PB:3.33
PE(LYR):25.95

Loading ...

Quest Diagnostics, Labcorp Shares Fall as Medicare Signals Cuts in Payment Rates for Lab Services

MT Newswires Live
·
Sep 22

Movement Alert|Quest Diagnostics Falls 6.08% in Pre-Market Trading, Trading at $230.0

Market Focus
·
Sep 22

Quest Diagnostics Study Finds 29.5% of Lyme-Seropositive Patients Show Antibodies to Other Tick-Borne Pathogens

Reuters
·
Sep 21

Truist Raises Price Target on Quest Diagnostics to $260 From $250, Keeps Hold Rating

MT Newswires Live
·
Sep 21

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Sep 16

Quest Diagnostics Inc. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Sep 15

Quanterix Names Yuri Fesko as Chief Medical Officer

Reuters
·
Sep 14

Quest Diagnostics Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 11

Apple Health app users can order labs from Quest Diagnostics

TIPRANKS
·
Sep 10

Quest Diagnostics Lab Testing to be Available for Purchase in Apple Health App Later This Year

Reuters
·
Sep 10

Quest Diagnostics Price Target Raised to $245.00/Share from $232.00 by UBS

Dow Jones
·
Sep 09

UBS Adjusts Quest Diagnostics Price Target to $245 From $232, Maintains Neutral Rating

MT Newswires Live
·
Sep 08

Quest Diagnostics Inc : UBS Raises Target Price to $245 from $232

THOMSON REUTERS
·
Sep 08

Quest Diagnostics CEO James E. Davis Sells 10,000 Shares Worth $2.43 Million

Reuters
·
Sep 04

Quest Diagnostics Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 03

Quest Diagnostics Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Sep 01

Quest Diagnostics SVP, General Counsel Michael E. Prevoznik Disposes of Shares Worth $5.52 Million

Reuters
·
Sep 01

3 Defensive Dividend Stocks for Investors Seeking Shelter From Market Volatility

Simply Wall St.
·
Aug 26

Quest Diagnostics Teams with Humanity to Offer Biological Age Analysis on Questhealth.com

Reuters
·
Aug 25

Quest Diagnostics CEO Jim Davis to Speak at Baird Global Healthcare Conference

Reuters
·
Aug 25